EichorEICHOR
Location: Gunma Synced from ClinicalTrials.gov · August 10, 2026

Clinical studies recruiting near Gunma

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Surgery Plus Chemo Versus Chemoradiotherapy Followed by Surgery Plus Chemo for Locally Recurrent Rectal Cancer
Phase 3 · National Cancer Center Hospital East · NCT04288999A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Pfizer · NCT05020236A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Maebashi North Hospital · Philip Morris Products S.A. · NCT07108166Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Daiichi Sankyo · NCT07022483A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Merck Sharp & Dohme LLC · NCT06393374This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in
Phase 3 · Pfizer · NCT06758401A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintena
Phase 3 · Merck Sharp & Dohme LLC · NCT07216703Software as a Medical Device for the Treatment of Patients With PTSD
Phase 2/Phase 3 · PTSD Care Matsumoto Mental Clinic · Otsuka Medical Devices Co., Ltd. Japan · NCT06589505Perioperative HLX10 (Serplulimab) With S-1+Oxaliplatin (SOX) in Locally Advanced and PD-L1-Positive Gastric or Esophagog
Phase 2 · National Cancer Center, Japan · NCT07699939A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
Phase 3 · Janssen Research & Development, LLC · NCT06319820A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel
Phase 3 · AbbVie · NCT04928846A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Phase 3 · Hoffmann-La Roche · NCT07416604A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
Phase 3 · Ota Memorial Hospital_Pediatrics · Novo Nordisk A/S · NCT05685238Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma
Phase 1/Phase 2 · Regeneron Pharmaceuticals · NCT03761108Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
Phase N/A · Research Site · AstraZeneca · NCT05454787A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study
Phase 2 · Astellas Pharma Global Development, Inc. · NCT02960022De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Gunma University Hospital · NRG Oncology · NCT04852887Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)
Phase N/A · TCROSS Co., Ltd. · NCT06436092Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failure
Phase 3 · Juntendo University · NCT05392764A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratum
Phase 3 · Pfizer · NCT05623020A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Phase 3 · Gunma University Hospital · Janssen Research & Development, LLC · NCT07518186Phase III Trial of Stage I Ovarian Cancer After Surgery
Phase 3 · Japanese Gynecologic Oncology Group · NCT04063527A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' D
Phase 2 · Immunovant Sciences GmbH · NCT07018323General Use-results Surveillance With Awiqli in Patients With Diabetes Mellitus
Phase N/A · Shimizu Naika · Novo Nordisk A/S · NCT06807190Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Ce
Phase 3 · Merck Sharp & Dohme LLC · NCT06422143Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Phase 3 · Pfizer · NCT05156398A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
Phase 3 · Merck Sharp & Dohme LLC · NCT07318558A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Th
Phase 3 · AbbVie · NCT05995353
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.